On June 14, 2021, Philips Respironics announced a voluntary recall for multiple Philips Bi-Level Positive Airway Pressure (Bi-Level PAP), Continuous Positive Airway Pressure (CPAP), and mechanical ventilator devices.
The recall stems from potential health risks the company identified in their devices’ polyester-based polyurethane (PE-PUR) sound abatement foam component. This component can disintegrate or outgas, causing users to inhale and/or ingest toxic and possibly carcinogenic substances. The recalled devices include those in the first-generation Dream Station product family (visit this FDA’S Philips Recall Page for a list of all recalled devices).
You could be eligible for compensation if you or a loved one used the recalled Philips medical devices and suffered adverse health outcomes, such as:
- Chronic Asthma
- Pneumonitis
- COPD
- Chronic Bronchitis (must recur more than once – list date of each recurrence)
- Recurring Pneumonia (3+ times in 18 months)
- Pulmonary Fibrosis
- Scarring of the lungs
- Interstitial lung
- Lip cancer
- Tongue cancer
- Salivary cancer
- Sarcoidosis
- Nasal cancer
- Sinus cancer
- Nasopharynx cancer
- Throat cancer
- Thyroid cancer (death cases only)
- Head and Neck cancer
- Lung cancer
- Bladder cancer
- Liver Cancer
- Lymphoma
- Multiple Myeloma
- Leukemia
We are taking CPAP cases where the device user:
- Used a qualified device prior to 4/25/2021; and
- Was under age 75 or under at time of diagnosis; and
- Was a non-smoker during the time the device was used; and
- Used the device for one year prior to being diagnosed with one of the above injuries.
Find out if you qualify for an existing class-action lawsuit, or contact our class action lawsuit attorneys at Rosenthal, Levy, Simon, and Sosa today to learn more about these large-scale lawsuits. Call us today to schedule an initial consultation.